Global Protein Sequencing Market to Reach $1.2 Billion by 2027

Abstract: - Global Protein Sequencing Market to Reach $1. 2 Billion by 2027. - Amid the COVID-19 crisis, the global market for Protein Sequencing estimated at US$957. 8 Million in the year 2020, is projected to reach a revised size of US$1.

New York, June 28, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Protein Sequencing Industry" - https://www.reportlinker.com/p06032698/?utm_source=GNW
2 Billion by 2027, growing at aCAGR of 3.1% over the period 2020-2027. Mass Spectrometry, one of the segments analyzed in the report, is projected to record 2.9% CAGR and reach US$757.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Edman Degradation segment is readjusted to a revised 3.4% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $281.5 Million, While China is Forecast to Grow at 3% CAGR
- The Protein Sequencing market in the U.S. is estimated at US$281.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$211.7 Million by the year 2027 trailing a CAGR of 3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 2.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

- Select Competitors (Total 34 Featured) -

• Agilent Technologies
• Bioinformatics Solution
• Charles River Laboratories
• Proteome Factory
• Rapid Novor
• Selvita
• SGS Limited (SA)
• Shimadzu Corp.
• Thermo Fischer Inc.
• Water Corporation

Read the full report: https://www.reportlinker.com/p06032698/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Protein Sequencing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 2: World Historic Review for Protein Sequencing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Protein Sequencing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Mass Spectrometry
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Mass Spectrometry by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Mass Spectrometry by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Edman Degradation
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Edman Degradation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Edman Degradation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Biotherapeutics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 11: World Historic Review for Biotherapeutics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Biotherapeutics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Genetic
Engineering by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 14: World Historic Review for Genetic Engineering by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Genetic Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 17: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Academic
Institutes & Research Centers by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Academic Institutes &
Research Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Academic Institutes &
Research Centers by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Pharma & Biotech
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 23: World Historic Review for Pharma & Biotech Companies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 26: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Protein Sequencing
by Technology - Mass Spectrometry and Edman Degradation -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2020 &
2027

Table 31: USA Current & Future Analysis for Protein Sequencing
by Application - Biotherapeutics, Genetic Engineering and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Protein Sequencing
by End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 35: USA Historic Review for Protein Sequencing by End-Use -
Academic Institutes & Research Centers, Pharma & Biotech
Companies and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 36: USA 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2020 & 2027

CANADA
Table 37: Canada Current & Future Analysis for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2020 &
2027

Table 40: Canada Current & Future Analysis for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 41: Canada Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Protein
Sequencing by End-Use - Academic Institutes & Research Centers,
Pharma & Biotech Companies and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 44: Canada Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 45: Canada 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2020 & 2027

JAPAN
Table 46: Japan Current & Future Analysis for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: Japan 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2020 &
2027

Table 49: Japan Current & Future Analysis for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 50: Japan Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Protein
Sequencing by End-Use - Academic Institutes & Research Centers,
Pharma & Biotech Companies and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: Japan Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 54: Japan 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2020 & 2027

CHINA
Table 55: China Current & Future Analysis for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: China 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2020 &
2027

Table 58: China Current & Future Analysis for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: China Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2020 & 2027

Table 61: China Current & Future Analysis for Protein
Sequencing by End-Use - Academic Institutes & Research Centers,
Pharma & Biotech Companies and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 62: China Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 63: China 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2020 & 2027

EUROPE
Table 64: Europe Current & Future Analysis for Protein
Sequencing by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Protein Sequencing by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Protein Sequencing by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2020 &
2027

Table 70: Europe Current & Future Analysis for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 71: Europe Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Protein
Sequencing by End-Use - Academic Institutes & Research Centers,
Pharma & Biotech Companies and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 74: Europe Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 75: Europe 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2020 & 2027

FRANCE
Table 76: France Current & Future Analysis for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 78: France 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2020 &
2027

Table 79: France Current & Future Analysis for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 80: France Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2020 & 2027

Table 82: France Current & Future Analysis for Protein
Sequencing by End-Use - Academic Institutes & Research Centers,
Pharma & Biotech Companies and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 83: France Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 84: France 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2020 & 2027

GERMANY
Table 85: Germany Current & Future Analysis for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: Germany 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2020 &
2027

Table 88: Germany Current & Future Analysis for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 89: Germany Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Protein
Sequencing by End-Use - Academic Institutes & Research Centers,
Pharma & Biotech Companies and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 92: Germany Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 93: Germany 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2020 & 2027

ITALY
Table 94: Italy Current & Future Analysis for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 95: Italy Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 96: Italy 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2020 &
2027

Table 97: Italy Current & Future Analysis for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 98: Italy Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Protein
Sequencing by End-Use - Academic Institutes & Research Centers,
Pharma & Biotech Companies and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 101: Italy Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 102: Italy 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 103: UK Current & Future Analysis for Protein Sequencing
by Technology - Mass Spectrometry and Edman Degradation -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 104: UK Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 105: UK 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2020 &
2027

Table 106: UK Current & Future Analysis for Protein Sequencing
by Application - Biotherapeutics, Genetic Engineering and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 108: UK 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2020 & 2027

Table 109: UK Current & Future Analysis for Protein Sequencing
by End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 110: UK Historic Review for Protein Sequencing by End-Use -
Academic Institutes & Research Centers, Pharma & Biotech
Companies and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 111: UK 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 112: Rest of Europe Current & Future Analysis for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 113: Rest of Europe Historic Review for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 114: Rest of Europe 15-Year Perspective for Protein
Sequencing by Technology - Percentage Breakdown of Value Sales
for Mass Spectrometry and Edman Degradation for the Years 2012,
2020 & 2027

Table 115: Rest of Europe Current & Future Analysis for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 116: Rest of Europe Historic Review for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 117: Rest of Europe 15-Year Perspective for Protein
Sequencing by Application - Percentage Breakdown of Value Sales
for Biotherapeutics, Genetic Engineering and Other Applications
for the Years 2012, 2020 & 2027

Table 118: Rest of Europe Current & Future Analysis for Protein
Sequencing by End-Use - Academic Institutes & Research Centers,
Pharma & Biotech Companies and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 119: Rest of Europe Historic Review for Protein
Sequencing by End-Use - Academic Institutes & Research Centers,
Pharma & Biotech Companies and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 120: Rest of Europe 15-Year Perspective for Protein
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Academic Institutes & Research Centers, Pharma & Biotech
Companies and Other End-Uses for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 121: Asia-Pacific Current & Future Analysis for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 122: Asia-Pacific Historic Review for Protein Sequencing
by Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 123: Asia-Pacific 15-Year Perspective for Protein
Sequencing by Technology - Percentage Breakdown of Value Sales
for Mass Spectrometry and Edman Degradation for the Years 2012,
2020 & 2027

Table 124: Asia-Pacific Current & Future Analysis for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 125: Asia-Pacific Historic Review for Protein Sequencing
by Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 126: Asia-Pacific 15-Year Perspective for Protein
Sequencing by Application - Percentage Breakdown of Value Sales
for Biotherapeutics, Genetic Engineering and Other Applications
for the Years 2012, 2020 & 2027

Table 127: Asia-Pacific Current & Future Analysis for Protein
Sequencing by End-Use - Academic Institutes & Research Centers,
Pharma & Biotech Companies and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 128: Asia-Pacific Historic Review for Protein Sequencing
by End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 129: Asia-Pacific 15-Year Perspective for Protein
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Academic Institutes & Research Centers, Pharma & Biotech
Companies and Other End-Uses for the Years 2012, 2020 & 2027

REST OF WORLD
Table 130: Rest of World Current & Future Analysis for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 131: Rest of World Historic Review for Protein Sequencing
by Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 132: Rest of World 15-Year Perspective for Protein
Sequencing by Technology - Percentage Breakdown of Value Sales
for Mass Spectrometry and Edman Degradation for the Years 2012,
2020 & 2027

Table 133: Rest of World Current & Future Analysis for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 134: Rest of World Historic Review for Protein Sequencing
by Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032698/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001